Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?

Cancer Rep (Hoboken). 2022 Aug;5(8):e1569. doi: 10.1002/cnr2.1569. Epub 2021 Oct 6.

Abstract

Background: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion.

Cases: We completed a single center retrospective review of children with neuroblastoma and ≥stage II hypertension (per Hypertension Canada guidelines) over a 2-year period. All patients (n = 10) had elevated urine normetanephrine levels and eight had intra-abdominal tumors. Four patients had refractory hypertension requiring > three agents, of which three required alpha/beta blockade.

Conclusion: Although multifactorial, hypertension in neuroblastoma often has a neuroendocrine component. Excess normetanephrine production in neuroblastoma may be a more common hypertensive mechanism than previously appreciated. Urinary normetanephrine elevation could suggest potential neuroendocrine-mediated hypertension.

Keywords: catecholamine; hypertension; metanephrine; neuroblastoma.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers
  • Catecholamines / urine
  • Child
  • Humans
  • Hypertension* / diagnosis
  • Hypertension* / etiology
  • Neuroblastoma* / diagnosis
  • Neuroblastoma* / urine
  • Normetanephrine / urine

Substances

  • Biomarkers
  • Catecholamines
  • Normetanephrine